Skip to main content

Catecholaminergic Polymorphic Ventricular Tachycardia: A Challenging Case of “Epilepsy”

  • Chapter
Clinical Cases in Cardiology
  • 2066 Accesses

Abstract

Children and young adults with potentially lethal cardiac channelopathies often present to medical care with a history of syncope or seizures due to episodic ventricular arrhythmias and associated cerebral hypoperfusion. Catecholaminergic polymorphic ventricular tachycardia is discussed using relevant case example. The pathophysiology and distinguishing clinical features of this condition is reviewed. Cardiac channelopathies can be misdiagnosed as refractory epilepsy when in fact these events represent convulsive syncopes. Knowledge of and suspicion for these arrhythmogenic conditions may improve diagnosis and outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Liu N, Ruan Y, Priori SG (2008) Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis 51:23–30

    Article  PubMed  Google Scholar 

  2. Mohamed U, Napolitano C, Priori SG (2007) Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 18:791–797

    Article  PubMed  Google Scholar 

  3. Napolitano C, Priori SG (2007) Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 4:675–678

    Article  PubMed  Google Scholar 

  4. Ylanen K, Poutanen T, Hiippala A et al (2010) Catecholaminergic polymorphic ventricular tachycardia. Eur J Pediatr 169:535–542

    Article  PubMed  Google Scholar 

  5. Wehrens XH (2007) The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms? Heart Rhythm 4:794–797

    Article  PubMed Central  PubMed  Google Scholar 

  6. Gyorke S (2009) Molecular basis of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 6:123–129

    Article  PubMed  Google Scholar 

  7. Baher AA, Uy M, Xie F et al (2011) Bidirectional ventricular tachycardia: ping pong in the His-Purkinje system. Heart Rhythm 8:599–605

    Article  PubMed Central  PubMed  Google Scholar 

  8. Tsuboi M, Antzelevitch C (2006) Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7). Heart Rhythm 3:328–335

    Article  PubMed Central  PubMed  Google Scholar 

  9. Van der Werf C, Kannankeril PJ, Sacher F et al (2011) Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol 57(22):2244–2254

    Article  PubMed Central  PubMed  Google Scholar 

  10. Hwang HS, Hasdemir C, Laver D et al (2011) Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol 4:128–135

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(10):e385–e484

    Article  PubMed  Google Scholar 

  12. Sy RW, Gollob MH, Klein GJ et al (2011) Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 8:864–871

    Article  PubMed  Google Scholar 

  13. Zipes DP, Ackerman MJ, Estes NA III et al (2005) Task Force 7: arrhythmias. J Am Coll Cardiol 45:1354–1363

    Article  PubMed  Google Scholar 

  14. Ackerman MJ, Priori SG, Willems S et al (2011) HRS/EHRA expert consensus statement on the State of Genetic Testing for the channelopathies and cardiomyopathies. Heart Rhythm 8:1308–1339

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura Cipolletta .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Cipolletta, L. (2015). Catecholaminergic Polymorphic Ventricular Tachycardia: A Challenging Case of “Epilepsy”. In: Capucci, A. (eds) Clinical Cases in Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-319-19926-9_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19926-9_26

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19925-2

  • Online ISBN: 978-3-319-19926-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics